傲農生物(603363.SH)擬與浙江康潤富簽訂租賃意向協議
格隆匯 7 月 27日丨傲農生物(603363.SH)公佈,為推動公司養殖業務發展,公司擬與浙江康潤富農業開發有限公司(“浙江康潤富”)簽訂租賃意向協議,並由浙江康潤富在金華市永康市建設存欄5000頭商品母豬+300頭原種母豬的自繁自養豬場(“永康豬場”),建成後出租給公司或公司控股子公司使用,租賃期為8年,年租金預計約人民幣2000萬元。
此次合作有助於加快推進公司在浙江區域的養殖業務佈局,穩步提升養殖業務規模,符合公司養殖業務發展戰略和經營規劃。此次合作協議的履行對公司2020年度經營業績無重大影響,對公司未來經營業績的影響有賴於未來合作協議、租賃合同的具體實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.